Lupin Shares Slump as Nagpur Facility Gets 6 Observations
Shares of Lupin Ltd were trading in the red and 1.5% lower on 17 September after the company’s Nagpur injectable facility received six observations from...
Tag : USFDA observations
Zydus Life Vadodara Unit Receives 4 USFDA Observations
Shares of Zydus Lifesciences Ltd were trading in the green and almost 1% higher on 8 September despite the company’s Vadodara unit receiving 4 observations...
Alembic Pharma Shares Slump 2% as Vadodara Unit Gets One Observation
Shares of Alembic Pharmaceuticals Ltd slumped as much as 2.8% on Monday, 10 March, after the company’s Bioequivalence facility in Vadodara was inspected by the...
Gland Pharma Receives Three Observations from USFDA
Gland Pharma Ltd announced on Tuesday, 25 February, that the U.S. Food and Drug Administration (USFDA) has completed a key inspection of its Andhra Pradesh...
Laurus Labs Shares Gain 2% Despite Receiving Arm Receiving One Observation
Shares of Laurus Labs Ltd rose 2% on 23 January despite the USFDA issuing one observation regarding the company’s overseas subsidiary. The US Food and...
Lupin Shares Slump 2% on Receiving 5 Observations from USFDA
Shares of Lupin Ltd were trading in the red and 2% lower on 7 October after the company announced receiving 5 observations from the USFDA. ...
Aurobindo Pharma Shares Drop 2.5% After USFDA Issues 10 Observations to Telangana API Unit
Shares of Aurobindo Pharma Ltd. fell by 2.5% after reaching a day’s high of Rs 1,518.90 on 30th September, following the company’s announcement that the...
Lupin Shares Slump 1% as Pithampur Facility Receives 3 Observations
Shares of Lupin Ltd were trading in the red and 1.75% lower on 30 September after the company announced that its Pithampur facility in Madhya...
Granules India Shares Fall 8% on 6 USFDA Observations
Shares of Granules India Ltd. fell 8% after reaching a day’s high of Rs 690 on 12th September, following six USFDA observations issued to the...
Gland Pharma Shares Slip 2% as USFDA Issued 2 Observations
Shares of Gland Pharma Ltd slipped 2% and hit an intra-day low of Rs 1,978.40 on 25 July after the company announced that the US...